Date published: 2025-12-11

1-800-457-3801

SCBT Portrait Logo
Seach Input

RhebL1 Activators

Common RhebL1 Activators include, but are not limited to Rapamycin CAS 53123-88-9, Insulin CAS 11061-68-0, AICAR CAS 2627-69-2, PI-103 CAS 371935-74-9 and Wortmannin CAS 19545-26-7.

RhebL1, also known as Ras homolog enriched in brain-like 1, is part of the Ras superfamily of small GTPases. Like other members of this superfamily, RhebL1 functions as a molecular switch, cycling between an active GTP-bound state and an inactive GDP-bound state. These conformational states allow RhebL1 to interact with various effector proteins, thereby influencing a range of cellular processes. The precise roles and pathways associated with RhebL1 are still subjects of active research, but its association with the Ras superfamily suggests involvement in signal transduction pathways, cellular growth, and cytoskeletal dynamics. The ability of RhebL1 to modulate these pathways underscores its significance in maintaining cellular homeostasis and facilitating responses to external and internal cues.

Activators of RhebL1 are molecules or compounds that enhance the activity or expression of RhebL1. These activators might function by promoting the transcription of the RhebL1 gene, by stabilizing the RhebL1 protein structure, or by promoting its transition to the active GTP-bound state. The presence of RhebL1 activators can influence the dynamics of the pathways in which RhebL1 is involved, modulating the cellular processes regulated by this GTPase. Exploring the domain of RhebL1 activators offers a window into the multifaceted world of small GTPase regulation and the intricate molecular networks that shape cellular responses. As our understanding of cellular signaling and GTPase function deepens, the role of RhebL1 and its activators emerges as an intriguing narrative, highlighting the complex molecular interplay that defines cellular behavior and fate.

SEE ALSO...

Product NameCAS #Catalog #QUANTITYPriceCitationsRATING

Rapamycin

53123-88-9sc-3504
sc-3504A
sc-3504B
1 mg
5 mg
25 mg
$62.00
$155.00
$320.00
233
(4)

An mTOR inhibitor, which could indirectly influence RhebL1's activity or expression given the interplay between mTOR and Rheb proteins.

Insulin

11061-68-0sc-29062
sc-29062A
sc-29062B
100 mg
1 g
10 g
$153.00
$1224.00
$12239.00
82
(1)

Known to activate the mTOR pathway, might have an indirect effect on RhebL1 expression.

AICAR

2627-69-2sc-200659
sc-200659A
sc-200659B
50 mg
250 mg
1 g
$60.00
$270.00
$350.00
48
(2)

AMPK activator, which could potentially modulate mTOR signaling and indirectly influence RhebL1.

Metformin

657-24-9sc-507370
10 mg
$77.00
2
(0)

Activates AMPK and could indirectly modulate mTOR signaling, potentially influencing RhebL1.

PI-103

371935-74-9sc-203193
sc-203193A
1 mg
5 mg
$32.00
$128.00
3
(1)

PI3K/mTOR inhibitor that might influence RhebL1 expression indirectly via modulation of the mTOR pathway.

Akt Inhibitor IV

681281-88-9sc-203809
sc-203809A
5 mg
25 mg
$173.00
$695.00
42
(1)

Inhibits AKT signaling, potentially affecting mTOR signaling and indirectly RhebL1.